Announcements
- OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
- OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
- OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results
- OrthoPediatrics Corp. Launches New RESPONSE Rib and Pelvic Fixation System for EOS Scoliosis
- OrthoPediatrics Corp. Named One of the 2024 Best Places to Work in Indiana
- OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024
- OrthoPediatrics Corp. Announces Preliminary Unaudited Financial Highlights for the Fourth Quarter & Full Year 2023
- OrthoPediatrics Corp. Announces Acquisition of Boston Orthotics & Prosthetics
- OrthoPediatrics Corp. Announces Launch of Specialty Bracing Division
More ▼
Key statistics
On Tuesday, OrthoPediatrics Corp (2X7:DEU) closed at 28.60, -3.38% below its post-IPO high of 29.60, set on Apr 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 28.20 |
---|---|
High | 28.60 |
Low | 28.20 |
Bid | 28.60 |
Offer | 28.80 |
Previous close | 28.20 |
Average volume | 0.00 |
---|---|
Shares outstanding | 23.79m |
Free float | 16.20m |
P/E (TTM) | -- |
Market cap | 728.57m USD |
EPS (TTM) | -0.9251 USD |
Data delayed at least 15 minutes, as of Apr 23 2024.
More ▼